Compounds > imipenem, anhydrous
Page last updated: 2024-08-26

imipenem, anhydrous and Chronic Kidney Diseases

imipenem, anhydrous has been researched along with Chronic Kidney Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Becker, P; Chausse, J; Gous, A; Milne, M; Mitton, B; Paruk, F; Said, M1
de Velde, F; de Winter, BCM; Harbarth, S; Huttner, A; Koch, BCP; Mouton, JW; Neely, MN; van Gelder, T; von Dach, E; Yamada, WM1
Al-Tawfiq, JA; Dib, J; Memish, ZA; Momattin, H1

Other Studies

3 other study(ies) available for imipenem, anhydrous and Chronic Kidney Diseases

ArticleYear
Evaluating the usefulness of the estimated glomerular filtration rate for determination of imipenem dosage in critically ill patients.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2022, 08-30, Volume: 112, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Anti-Bacterial Agents; Cilastatin, Imipenem Drug Combination; Creatinine; Critical Illness; Female; Glomerular Filtration Rate; Humans; Imipenem; Male; Middle Aged; Renal Insufficiency, Chronic; Sepsis; South Africa; Young Adult

2022
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate.
    Clinical pharmacokinetics, 2020, Volume: 59, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Critical Illness; Female; Glomerular Filtration Rate; Humans; Imipenem; Male; Middle Aged; Renal Insufficiency, Chronic

2020
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 20

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Coronavirus; Coronavirus Infections; Critical Illness; Diabetes Mellitus; Female; Humans; Hypertension; Imipenem; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency, Chronic; Respiration, Artificial; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult

2014